Top gappers on : INO, CLRO and EVGO
Premarket
Monday's Small Caps: INO Has FDA Approval, PERI Has a Cash Deal, CLRO Has Questions
INO surges after accelerated approval, PERI trades below its $11.70 cash agreement, and CLRO draws heavy volume without a verified fresh catalyst. A source-linked small-cap brief…
Monday, November 2, 2026 · Premarket
INO has an FDA decision behind its move. PERI has a signed cash acquisition agreement. CLRO has heavy trading, but the fresh catalyst remains unverified. These three names illustrate why a small-cap watchlist needs both a price screen and a check of the underlying disclosure.
The following figures are from the FennEdge Scanner premarket view, showing an as-of time of 9:10:21 a.m. New York time on November 2.